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ABSTRACT 
Nitric oxide (NO) is associated with intestinal apoptosis in health and disease. This study aimed 
to investigate the role of intestinal NO in the regulation of apoptosis during fasting in rats. Male 
Wistar rats were divided into two groups and subcutaneously injected with saline (SA) or 
aminoguanidine (AG), followed by fasting for 24, 48, 60 and 72 h. At each time point, the 
jejunum was subjected to histological evaluation for enterocyte apoptosis using 
histomorphometric assessment and TUNEL analysis. We performed immunohistochemistry for 
inducible NO synthase (iNOS) expression in the jejunum and measured tissue nitrite levels using 
HPLC and 8-hydroxydeoxyguanosine adduct using ELISA, indicative of endogenous NO 
production and reactive oxygen species (ROS) production, respectively. Jejunal transcriptional 
levels of iNOS, neuronal NO synthase (nNOS) and interferon-γ (IFN-γ) were also determined 
using RT-PCR. Fasting caused significant jejunal mucosal atrophy due to increased apoptosis, 
and attenuated cell proliferation with increased iNOS transcription, its protein expression in 
intestinal epithelial cells (IEC), and jejunal nitrite levels. However, AG treatment histologically 
reduced apoptosis with inhibition of fasting-induced iNOS transcription, protein expression, and 
nitrite production. We also observed fasting-induced ROS production and subsequent IFN-γ 
transcription, which were all inhibited by AG treatment. Furthermore, we observed reduced 
transcriptional levels of nNOS, known to suppress iNOS activation physiologically. These 
results suggest that fasting-induced iNOS activation in IEC may induce apoptosis mediators 
such as IFN-γ via a ROS-mediated mechanism, and also a possible role of nNOS in the 
regulation of iNOS activity in fasting-induced apoptosis. 
 
Keywords: Fasting, Apoptosis, Nitric oxide (NO), Inducible NO synthase (iNOS), Interferon-γ 
(IFN-γ) 
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INTRODUCTION 
  The gastrointestinal epithelium is a dynamic tissue characterized by a high cellular turnover 
rate with a balance between cell proliferation and cell apoptosis, consequently leading to 
renewal of the entire intestinal epithelium every 3 to 5 days (9, 19). This single layer of cells 
lining the gut lumen acts as a barrier against harmful intraluminal entities, including foreign 
antigens, microorganisms and toxins, and also acts as a selective filter allowing the translocation 
of essential dietary nutrients, electrolytes and water. However, these physiological functions are 
occasionally impaired under pathological conditions such as inflammation and 
ischemia-reperfusion, and are accompanied by intestinal histological changes, including 
apoptosis.  
  Fasting is likely a physiological challenge evoking a response to the absence of luminal 
nutrients by functional and morphological changes, including intestinal epithelial apoptosis (8, 
13, 21). However, prolonged fasting not only impairs intestinal physiological functions, but also 
brings about intestinal barrier dysfunction, including increased epithelial permeability and 
impaired tight junctions, subsequently leading to bacterial translocation in patients receiving a 
prolonged course of total parenteral nutrition (TPN) (56). Recent studies also show that 
proinflammatory cytokine-induced apoptosis causes loose epithelial tight junctions and an 
increase in paracellular permeability, raising a possibility of apoptosis-mediated intestinal 
barrier dysfunction (3, 44).  
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  Among the many factors affecting the regulation of apoptosis, considerable attention has been 
given to the possible contribution of nitric oxide (NO) in the process of intestinal apoptosis (4, 
35, 53, 57) and barrier dysfunction. Recent reports describing the link between NO and intestinal 
barrier functions demonstrated that inhibition of inducible NO synthase (iNOS) reduces bacterial 
translocation with a decrease in enterocyte apoptosis in LPS-induced rat intestinal injury (12), 
and improves intestinal barrier dysfunction induced by prolonged oral TPN feeding in rats (23).  
  According to recent knowledge, apoptosis is regulated through two distinct pathways 
converging to sequential activation of cysteine proteases of the caspase family, leading to the 
common final events of DNA-fragmentation (14, 33, 50). The intrinsic type-2 pathway occurs in 
response to diverse stresses, including ischemia-reperfusion via a mitochondria-mediated 
pathway following the release of cytochrome c from damaged mitochondria. On the other hand, 
fasting promotes intestinal mucosal apoptosis through ligand-mediated trimerization of death 
receptors of the tumor necrosis factor (TNF) family, that is, the so-called extrinsic pathway 
(type-1 apoptotic pathway). Although most reports have investigated the relationships of caspase 
activity and cytokine levels on intestinal apoptotic morphology in fasting animal models (2, 9, 
16, 27), the NO contribution to fasting-mediated intestinal mucosal apoptosis remains to be 
elucidated, especially in the early phase of fasting. Therefore, the aim of the present study was to 
investigate the mechanism of fasting-induced intestinal apoptosis with respect to the role of 
NOS in the regulation of intestinal mucosal apoptosis during the early phase of fasting in rats.  
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MATERIALS AND METHODS 
Animals and experimental design 
  The experimental protocol and design were approved by the Institutional Animal Care and 
Use Committee at the Life Science Center of Josai University and were consistent with the 
Guide for the Care and Use of Laboratory Animals published by the NIH. Male Wistar rats 
weighing 200-220 g (at 9 weeks of age) were purchased from SLC Inc. (Shizuoka, Japan), and 
were housed individually in wire-bottomed cages to prevent coprophagia, in a room illuminated 
from 7:00 a.m. to 7:00 p.m. (12:12-h light-dark cycle). The rats were allowed free access to 
deionized water and standard rat chow (CE-2, CLEA Japan) ad libitum until the study began. At 
10 weeks of age, seventy rats were randomly divided into two groups (Fig. 1): saline (SA) group 
and aminoguanidine (AG) group. Each group was further divided into five subgroups as follows: 
1) SA + ad libitum, 2) SA + 24-h fast, 3) SA + 48-h fast, 4) SA + 60-h fast, 5) SA + 72-h fast, 6) 
AG (a relatively selective iNOS inhibitor) + ad libitum, 7) AG + 24-h fast, 8) AG + 48-h fast, 9) 
AG + 60-h fast, 10) AG + 72-h fast. All groups were subcutaneously administrated with SA or 
AG (20 mg/kg) (47), 18 h before, and 6, 30 and 54 h after fasting. The rats fasted for 24 h, 48 h, 
60 h and 72 h underwent food withdrawal with only water being supplied. The rats were 
weighed every day. 
 We chose AG as an iNOS inhibitor. Although new iNOS inhibitors such as (1S, 5S, 6R, 
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7R)-2-aza-7-chloro-3-imino-5-methylbicyclo [4.1.0] heptane hydrochloride (ONO-1714) or 
N-(3-(aminomethyl)benzyl)acetamidine (1400W) have been developed and are being used as 
more selective iNOS inhibitors than AG in conditions such as sepsis-associated lung injury and 
lung dysfunction in endotoxemia (40, 58), accumulated references regarding the dose and timing 
of AG administration are available for consistent interpretation of inhibition studies of iNOS, 
especially in the intestine (46, 47, 48).  
 
Collection of intestinal mucosa 
  After fasting with SA or AG, animals were anesthetized and then euthanized by 
exsanguination between 9.00 and 11.00 a.m. (except for 60-h fast: between 8.00 and 10.00 p.m.). 
The entire small intestine was carefully removed and placed on ice. The lumen of the intestine 
was flushed with 20 ml of ice-cold phosphate-buffered saline (PBS) to clear the intestinal lumen. 
The oral 10 cm part of the intestine was treated as the duodenum, and the rest of the intestine 
was divided into two segments representing proximal (jejunum) and distal (ileum) ends. The 
segments used for several analyses were the jejunum, from 3 to 5 cm distal to the duodenum 
(16). Some pieces, approximately 3 cm in length, were fixed in 10% neutral buffered formalin 
for measurement of mucosal height and for immunohistochemistry. Other segments were 
snap-frozen in liquid nitrogen and stored at -80 °C until use. 
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Histopathological analysis, including apoptotic index, terminal deoxynucleotidyl transferase 
(TdT)-mediated dUDP-biotin nick-end labeling (TUNEL) staining and cell proliferation     
  Tissue samples fixed in 10% neutral buffered formalin were then embedded in paraffin and 
sectioned. The specimens were stained with hematoxylin and eosin (HE). Mucosal height 
(villous height plus crypt depth) was measured using a microscope (Olympus BX41, Japan) and 
a digital camera system (Pixera Penguin 150CL, USA) for ad libitum-fed and fasted rats. 
Mucosal height was measured in at least 30 villi per animal. 
  In order to detect enterocyte apoptosis in the jejunal villus, both TUNEL staining and 
apoptotic index (AI) were used. TUNEL staining is easy to interpret over all images for 
apoptosis; however, because of its nonspecific staining (28), representative apoptotic changes 
were also detected for the analysis of AI using conventional light microscopy of HE-stained 
specimens. We followed the method described by Dahly, Guo, and Ney (11). In brief, jejunal 
sections were examined for apoptotic enterocytes in a blinded manner by an experimental 
pathologist (H.U.) based on the characteristic findings of apoptotic cells, including condensed 
chromatin, nuclear fragmentation, intensely eosinophilic cytoplasm and formation of apoptotic 
bodies (Fig. 6A). Fifty villus columns were assessed per rat (n=7 rats per subgroup). For each 
villus column assessed (i.e., one side of the villus in a longitudinal cross-section), the number 
and position of apoptotic cells, as well as the total number of cells in the villus column, were 
recorded. To account for the effects of fasting and AG treatment on apoptosis, the ratio of 
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apoptotic cells to one villus column and AI were determined. The mean number of apoptotic 
cells per villus column was calculated by dividing the total number of apoptotic cells in the 
well-oriented villus cell columns by 50 for each rat. In addition, AI was quantified by counting 
the total number of apoptotic cells in the 50 well-oriented villus columns and expressing this as 
the percentage of the total number of cells in the 50 villus columns for each rat.  
  To identify locations of apoptosis along the villus, AI distribution curves were constructed 
based on group means that plotted cell position vs. AI at each position. AI, in this case, was 
defined as the total number of apoptotic cells at each cell position expressed as the percentage of 
the total number of cells counted at that cell position.  
  Fragmented DNA was stained using the TUNEL method (17), with an Apoptosis in situ 
Detection KIT (Wako, Japan). The specimens were dewaxed and incubated with 20 μg/ml 
proteinase K for 20 min at 37 °C, the reaction was terminated with buffer containing bovine 
serum, and then the specimens were incubated for 5 min. PBS was applied directly on the 
specimens for 10 min at room temperature. Subsequently, 100 μl of terminal deoxynucleotidyl 
transferase (TdT) reaction solution was added, and the mixture was incubated at 37 °C for 25 
min. In additional control sections, TdT reaction solution was omitted. The specimens were 
incubated successively with PBS containing 3% hydrogen peroxide for 20 min at room 
temperature to inactive endogenous peroxidases, and then were covered with 100 μl of 
horseradish peroxidase (POD)-conjugated antibody solution, and incubated for 10 min at 37 °C. 
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The specimens were soaked in PBS for 10 min, and then covered with 100 μl of 
3,3’diaminobenzidine tetrahydrochloride (DAB) solution for 2 min at room temperature for 
color development. Finally, the specimens were counterstained with hematoxylin and examined 
with a light microscope. A minimum of 30 villi were randomly selected for TUNEL staining, and 
the number of TUNEL-positive cells was calculated. The TUNEL-positive rate was determined 
by dividing the number of cells by the total number of cells in the villi and multiplying by 200. 
  Crypt cell proliferation was assessed by using 5-bromo-2’-deoxyuridine (5-BrdU) 
incorporation to identify cells in the S phase of the cell cycle (49). 5-BrdU 
immunohistochemistry staining was performed by an anti-5-BrdU monoclonal antibody and a 
VECTASTAIN Elite ABC KIT (Vector Laboratories, USA). Rats were given intraperitoneal 
injections of 100 mg/kg 5-BrdU 60 min before sacrifice. The specimens were dewaxed and were 
immersed in 3% hydrogen peroxide-methanol solution for 20 min. The specimens were washed 
with PBS and denatured in 2N hydrochloric acid solution for 20 min. The specimens were 
washed with PBS and were immersed in 0.1M boric-acid buffer solution (pH 8.5) for pH control 
at 5 min. The specimens were incubated with 20 μg/ml proteinase K for 25 min at 37 °C, the 
reaction was terminated with PBS containing bovine serum, and then the specimens were 
incubated for 5 min. The specimens were covered with 300 μl of mouse anti-5-BrdU monoclonal 
antibody (1: 50; Chemicon International, CA) solution and incubated for 1 h at 37 °C. In 
additional control sections, the primary antibody was omitted. The specimens were covered with 
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biotinylated goat anti-mouse IgG antibody (1 : 200; Vector Laboratories, USA) solution. After 
the specimens were washed with PBS for 10 min, they were incubated with 
avidin-biotin-peroxidase complex solution for 1 h at room temperature. Color development was 
performed at room temperature in a substrate medium containing 0.05% DAB-H2O2 solution. 
Finally, the specimens were counterstained with hematoxylin. The number of labeled cells in at 
least 10 well-oriented longitudinal crypts in each sample was determined under a light 
microscope. The result is shown as the number of 5-BrdU-labeled cells among the crypt cells. 
 
Immunohistochemistry of iNOS 
  Immunohistochemical staining of iNOS was performed with an anti-iNOS polyclonal 
antibody and a VECTASTAIN Elite ABC KIT (Vector Laboratories, USA) (32). The specimens 
obtained from the jejunum after 24-h, 48-h, and 72-h fasting as well as ad libitum rats were 
dewaxed and treated for antigen retrieval by boiling in 10 mM citrate buffer (pH 6.0) for 20 min 
at 95 °C (44). After being washed with PBS, sections were incubated in 6% hydrogen peroxide 
for 1 h and washed again with PBS. Nonspecific binding was blocked with a 20% goat serum 
solution in PBS for 10 min at room temperature. Sections were incubated with rabbit anti-iNOS 
polyclonal antibody (1:100; BD Transduction Laboratories, USA). In additional control sections, 
the primary antibody was omitted. A biotinylated goat anti-rabbit IgG (1:200; VECTASTAIN, 
USA) was used as a secondary antibody. Sections were then treated with VECTASTAIN Elite 
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ABC KIT, and reaction products were detected using color development at room temperature in 
a substrate medium containing a 0.05% DAB-H2O2 solution. Finally, the specimens were 
counterstained with hematoxylin and examined with a light microscope and a digital camera 
system. 
 
Nitrite concentrations in jejunum 
  Tissue samples stored at -80 °C were measured for nitrite concentrations using a dedicated 
HPLC system (ENO-20; EiCom, Japan). This method is based on the separation of nitrite and 
nitrate by ion chromatography, followed by on-line reaction of nitrate to nitrite, post-column 
derivatization with Griess reagent, and detection at 540 nm. Proteins in each sample were 
removed by centrifugation at 10,000 g for 5 min following methanol precipitation (jejunum : 
methanol = 1 : 2 weight/volume, 4 °C) (26). 
 
Analysis of iNOS, neuronal NOS (nNOS) and interferon-gamma (IFN-γ) mRNA expression 
by reverse transcription-polymerase chain reaction (RT-PCR) 
  Tissue samples stored at -80 °C were extracted using TaKaRa RNAiso Reagent (TaKaRa Bio, 
Japan) according to the manufacturer’s instructions. Total RNA concentrations were quantified 
by spectrophotometry at 260 nm. RT-PCR was performed with 1 mg of total RNA using an RNA 
PCR kit (AMV) Ver. 3.0 (TaKaRa Bio, Japan) according to the manufacturer’s instructions: 1 
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cycle at 42 °C for 30 min, 99 °C for 5 min, and 5 °C for 5 min for reverse transcription; and 30 
cycles at 94 °C for 30 sec, 60 °C for 30 sec, and 72 °C for 1 min for PCR. PCR was performed 
using a RoboCycler 96 gradient temperature cycler (Stratagene, CA). The oligonucleotides used 
as primers were synthesized by TaKaRa Bio, Japan. The primer pairs were designed as follows 
(product size and Primer ID provided by TaKaRa Bio are shown in parentheses): iNOS forward 
primer, 5’-ctcactgtggctgtggtcaccta-3’; and iNOS reverse primer, 5’-gggtcttcgggcttcaggtta-3’ 
(101 bp, RA008296). In addition, because intraepithelial lymphocyte (IEL)-derived IFN-γ is 
reported to evoke enterocyte apoptosis with parenteral nutrition (55), we considered a possible 
involvement of IFN-γ in fasting-induced apoptosis. We therefore performed RT-PCR for IFN-γ: 
IFN-γ forward primer, 5’-aggccatcagcaacaacataagtg-3’; reverse primer, 
5’-gacagctttgtgctggatctgtg-3’ (140 bp, RA021293). Based on recent reports showing nNOS 
involvement in the regulation of iNOS expression in the small intestine (18, 39), we also 
performed additional RT-PCR for nNOS: nNOS forward primer, 5’-tcaaagccatccagcgcata-3’; and 
nNOS reverse primer, 5’-gcggttggtcacttcatacgttc-3’ (146 bp, RA022317). Target mRNA 
expressions were quantified relative to the expression of glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH): GAPDH forward primer, 5’-ggcacagtcaaggctgagaatg-3’; and GAPDH 
reverse primer, 5’-atggtggtgaagacgccagta-3’ (143 bp, RA015380). A portion of each PCR 
mixture was electrophoresed in 2% agarose gel in TBE buffer (89 mM Tris, 89 mM boric acid, 2 
mM EDTA, pH 8.3), and the gel was visualized by ethidium bromide staining. The intensity of 
13 
 
the PCR products was measured using a Gene Genius Bioimaging System (SYNGENE, UK), 
and the ratios of iNOS, nNOS and IFN-γ expression relative to GAPDH expression were 
calculated for each sample. 
 
DNA oxidation analysis 
The generation of reactive oxygen species (ROS) in the jejunum was estimated by 
8-hydroxydeoxyguanosine (8-OHdG) levels in DNA (24). 8-OHdG is a product of oxidative 
DNA damage following specific enzymatic cleavage after 8-hydroxylation of the guanine base 
and has been proposed as an index of oxidative DNA damage reflecting the repair rate from 
DNA (45). Jejunal DNA was purified by DNA Extractor TIS Kit (Wako, Japan) using sodium 
iodide (NaI) as a chaotropic agent and an oxidation inhibitor. DNA was pretreated as follows: 
200 μg of sample, obtained by DNA preparation from the jejunum of a rat, was dissolved in 135 
μl of water, and after addition of 15 μl 200 mM sodium acetate containing 6 units of nuclease P1 
(Wako, Japan), samples were incubated for 1 h at 37 °C. Fifteen microliters of 1 M Tris-HCl 
buffer, pH 7.4, and 2 units of alkaline phosphatase (Wako, Japan) were then added and 
incubation was continued for 1 h. Hydrolysates were filtered through a VIVASPIN 500 MWCO 
10,000 (Sartorius Stedim, Germany) device at 14,000 rpm for 10 min, and 50 μl of filtrate was 
applied to the wells of the ELISA plate. The levels of 8-OHdG in the samples were determined 
with an ELISA kit (Japan Institute for the Control of Aging, Shizuoka, Japan). The kit can 
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measure extremely low levels of 8-OHdG, and the specificity of the monoclonal antibody has 
been established (41). The wells were subjected to optical density measurement at 450 nm. 
8-OHdG ELISA was performed in triplicate and the means were calculated. The data, expressed 
as picograms of 8-OHdG per microgram of DNA, were calculated on the basis of a linear 
calibration curve generated for each experiment with 8-OHdG standard solutions. 
 
Statistical analysis 
  Statistical analyses were performed using Dr SPSS II for Windows. All values are expressed 
as means ± SE. One-way ANOVA followed by a Bonferroni multiple comparisons test was used 
for analyzing the statistical difference between the fasting periods in SA- or AG-treated groups. 
Two-way ANOVA followed by a Bonferroni multiple comparisons test was used for analyzing 
the statistical difference between the SA- and AG-treated groups for the fasted periods. 
Statistical significance was accepted at a value of P <0.05. 
 
 
RESULTS 
Body weight changes 
  Figure 2 shows body weight changes expressed as the ratio of after/before fasting in 
SA-treated and AG-treated rats. Gradual decreases in body weight both in SA- and AG-treated 
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groups were observed along with fasting. Rats fasted for 72 h with SA and AG treatment showed 
an approximately 19% (P <0.05) and 18% (P <0.05) body weight loss, respectively, compared to 
ad libitum-fed control rats. There was no significant difference in weight loss at each fasting 
period between the SA and AG treatment, suggesting AG has no impact on fasting-induced body 
weight loss. 
 
Histological characterization of jejunal mucosal atrophy in fasted rats treated with SA or AG 
  Decreasing jejunal mucosal height both in SA- and AG-treated rats was observed along with 
fasting. However, significant differences (P <0.05) in jejunal mucosal height were found 
between the SA- and AG-treated rats at 48 h, 60 h, and 72 h fasting periods, suggesting that AG 
significantly inhibited progressive jejunal mucosal atrophy in fasted rats (Fig. 3).  
  In order to evaluate how reduced cell proliferation and/or increased cell apoptosis contributes 
to jejunal mucosal atrophy, we assessed 5-BrdU incorporation to the cells and TUNEL staining 
of the jejunum, indicative of cell proliferation and apoptosis in the jejunum, respectively. 
Although decreases in cell proliferation along with fasting were observed irrespective of the 
presence or absence of AG (Fig. 4), fasting remarkably induced jejunal cell apoptosis, which 
was completely inhibited by AG over all of the fasting periods as observed by TUNEL staining 
and TUNEL-positive rate (Figs. 5A and 5B). Conventional light microscopy for detecting 
representative apoptotic changes also showed an increased ratio of apoptotic cells to one villus 
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column and AI (6.8- to 8.6-fold increase: P <0.05) in fasted rats with SA, as well as significant 
inhibitory effects of AG on fasting-induced apoptosis over the indicated fasting periods (Table 1). 
For better identification of locations of apoptosis along the villus compartments, AI distribution 
curves were constructed by detecting representative apoptotic changes by conventional light 
microscopy of HE-stained specimens. Although many TUNEL-positive cells were observed in 
the tip of the jejunal villus in fasted rats (Fig. 5A), AI distribution curves showed increased 
apoptosis throughout the whole jejunal villus of fasted rats, with peak incidence of apoptosis in 
the bottom half of the villus compared to ad libitum-fed rats (Fig. 6B). Similar to the inhibitory 
effect of AG on AI, decreases in apoptosis by AG treatment were also observed in the AI 
distribution curves (Fig. 6B). 
 
Nitrite levels in the jejunum 
  Similar to the inhibitory effect of AG on intestinal apoptosis, AG, a selective iNOS inhibitor, 
also significantly inhibited the increasing accumulation of intestinal nitrite, a stable oxidation 
product of endogenous NO, especially in fasting (Fig. 7), suggesting that iNOS-induced NO 
might act as an important mediator of intestinal apoptosis in fasting rats.  
 
Intestinal transcriptional expression of iNOS and IFN-γ 
  Next, we tried to demonstrate the causative effect of iNOS on intestinal apoptosis by 
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evaluating transcriptional levels of iNOS during fasting. Figure 8 shows that fasting induced 
iNOS mRNA, which was suppressed by AG. Because of intimate anatomical localization of IEL 
located at basolateral surfaces of intestinal epithelial cells (IEC), possibly implicating a 
functional dialogue between the two cells, recent reports indicated phenotypic changes of IEC 
during administration of total parenteral nutrition via IEL-derived cytokines such as IFN-γ (54, 
55, 59). We therefore investigated the effects of fasting and AG treatment on transcriptional 
expression of IFN-γ. Figure 9 shows that fasting induced IFN-γ mRNA, which was also 
inhibited by AG, possibly suggesting that iNOS-related transcriptional induction of IFN-γ 
following fasting might exist in the intestinal mucosa. 
 
Immunohistochemical localization of iNOS 
  Immunostaining for iNOS was performed to localize the expression of iNOS protein in the 
jejunum. The ad libitum rats revealed negligible iNOS staining in the crypts and little positive 
staining was recognized in the cytoplasm at the villus-tip epithelial cells (Fig. 10 A-1 and A-2). 
These findings diminished with AG treatment in ad libitum fed rats (Fig. 10 B-1 and B-2). 
However, 24-h fasting showed heavily positive iNOS immunostaining along the mucosal 
epithelial monolayer of the jejunum (Fig. 10 C-1 and C-2). These iNOS immunoreactivities were 
almost completely inhibited by AG treatment (Fig. 10 D-1 and D-2). Similar results were 
observed in 48-h and 72-h fasting. In addition, the distribution of iNOS protein expressed along 
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with villus is histologically consistent with that of cell apoptosis observed in the 
histomorphometric assessment (Fig. 6B).  
 
Intestinal transcriptional expression of nNOS 
  As there are reports showing that nNOS plays an important role in the regulation of iNOS 
expression in the small intestine of fasting animal models (18, 39), intestinal transcriptional 
levels of nNOS were also investigated to evaluate the effect of fasting on nNOS transcription in 
the jejunum. In contrast to the fasting-induced increase in iNOS mRNA and protein expression 
(Figs. 8 and 10), a reduced nNOS transcription after fasting was observed (Fig. 11), possibly 
suggesting a reverse relationship between nNOS and iNOS at least at the transcriptional level. 
 
Intestinal DNA oxidative damage 
  The 8-OHdG levels were also investigated to evaluate the effect of fasting on the ROS 
generation in the jejunum (Fig. 12). In SA-treated groups, fasting increased jejunal 8-OHdG 
levels at 24 h, 48 h, and 72 h fasting periods compared with the ad libitum-fed rats (P< 0.05). 
AG significantly (P< 0.05) inhibited the fasting-induced increases in the jejunal 8-OHdG levels 
at 48 and 72 h fasting periods compared with the respective SA-treated group at each fasting 
period. Considering the AG inhibitory effect on increased IFN-γ induction and ROS production 
after fasting (Fig. 9, 12), iNOS-induced NO might play a central role upstream in the process of 
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fasting-induced apoptosis in which IFN-γ and ROS might be involved. 
 
 
DISCUSSION 
  Gut mucosal homeostasis depends on a balance between cell proliferation and cell death (15, 
27, 37). In the present study, incremental fasting resulted in jejunal mucosal atrophy caused by 
both decreased crypt stem cell proliferation and increased villus cell apoptosis. We applied 
TUNEL staining for detection of apoptotic cells (9). TUNEL staining allows easy observation of 
apoptotic distribution over tissue sections; however, because of its nonspecific staining (28), we 
also used conventional light microscopy for detection of characteristic apoptotic changes in 
HE-stained specimens. This method is extremely precise and presently considered the reference 
standard (36) if representative morphologic changes are observed (22). Consistent with the 
results from TUNEL-positive rate, we observed fasting-induced apoptosis and its improvement 
with AG using this histomorphometric assessment. However, the distribution of apoptotic cells 
is spread throughout the whole villus with predominant localization at the bottom one-half of the 
villus in the histomorphometric assessment (Fig. 6B), whereas apoptosis is confined to the top 
one-half of the villus in TUNEL staining (Fig. 5A), despite using carefully controlled techniques 
on rapidly fixed tissues to avoid nonspecific staining. It has been suggested by Merritt et al that 
senescent cell suicide particularly evident on the villus tip may have different temporal and even 
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genetic regulation from that of damage-induced apoptosis observed in the crypts treated with 
irradiation or TPN (11, 31). The difference in methodology between histomorphometric 
assessment and TUNEL staining might have some influence on the localizations of apoptotic 
cells in the villi, as observed in the present study. The precise mechanism involved still remains 
to be elucidated, and further investigation will be required to interpret this issue.  
  In the present study, we indicated that fasting-induced apoptosis might be mediated by iNOS, 
which is supported by increasing tissue levels of nitrite (Fig. 7), the stable oxidation product of 
endogenous NO especially in fasting, and the increase in both transcriptional and protein levels 
of iNOS in atrophied jejunal mucosa observed as early as 24 h after fasting (Figs. 8 and 10). In 
order to examine how iNOS-induced NO may be related to fasting-induced apoptosis, an iNOS 
inhibition study was also carried out using AG, a selective iNOS inhibitor. Decreasing jejunal 
mucosal height with progressive fasting was significantly inhibited by AG (Fig. 3), which 
suppressed mucosal cell apoptosis without having any effects on the decreasing cell proliferation 
index (Fig. 4). We are convinced that iNOS plays a central role in fasting-induced intestinal 
apoptosis, because AG treatment histologically improved apoptosis (Figs. 5 and 6) accompanied 
with inhibition of increased iNOS transcription and protein expression (Figs. 8 and 10), 
increased ROS production (Fig. 12) and increased IFN-γ transcription (Fig. 9) following fasting, 
suggesting that iNOS-induced NO might be working upstream in the process of fasting-induced 
apoptosis (Fig. 13).  
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  The causative effect of NO on apoptosis has been well documented. Depending on cell types 
and NO concentrations at the site where NO is produced, NO is a bifunctional regulator of 
apoptosis (7, 29). Low levels of NO exposure through the activation of endogenous NOS and 
slow release rates from NO donors are associated with anti-apoptotic effects, whereas under 
some conditions such as inflammation or neurodegenerative diseases, NO-dependent apoptosis 
(pro-apoptotic) has been observed (6). Recently, it has been clearly demonstrated that 
ischemia/reperfusion-induced apoptosis as a pathological state is related to the type-2 apoptosis 
pathway, in which cytochrome c release from the mitochondria triggers intrinsic apoptosis by 
opening mitochondrial permeability transition pores (16, 52).  
  Although the role of NO in the regulation of fasting-induced apoptosis has been less well 
documented so far, we considered that this apoptosis might be mediated by the type-1 
death-pathway, mainly based on the previous observation by Fujise et al (16) using the same 
experimental setting as in our present study. From our present results, we cannot determine 
whether NO works via type-1 death-pathway-mediated apoptosis. However, if we pay attention 
to IFN-γ, we are able to hypothesize that ROS-mediated IFN-γ might induce intestinal apoptosis 
through the type-1 death-pathway, because ROS is a main inducer of IFN-γ from IEL in the 
intestine. We therefore performed additional experiments examining a possible contribution of 
ROS in iNOS-induced apoptosis by measuring 8-OHdG levels, consequently showing an 
increased intestinal ROS production following fasting, which was reversed by AG treatment (Fig. 
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12), indicating a ROS-involved mechanism in this iNOS-induced apoptosis pathway (Fig. 13). 
Recent evidence shows that IEL-derived IFN-γ evokes enterocyte apoptosis via an up-regulation 
of Fas/FasL, leading to the increase in sensitivity of epithelial cells to Fas-mediated apoptosis 
(30, 55) through the type-1 pathway (55). It has been suggested that complex reciprocal 
interactions exist between IEC and IEL (20, 55); therefore, it is likely that IEC and IEL form a 
reciprocal feedback loop in which iNOS-released NO, physiologically present in IEC, stimulates 
IFN-γ production in IEL through a ROS-mediated mechanism (1, 5, 38), then IFN-γ stimulates 
further iNOS-derived NO production, resulting in further IFN-γ production and subsequent IEC 
apoptosis (Fig. 13). 
  Since AG, a selective iNOS inhibitor, generally inhibits iNOS activity via binding to its active 
centre according to its crystal structural analysis (10), the inhibition may act at the 
post-translational rather than at the transcriptional level. Our present study, however, showed 
that AG inhibited fasting-induced iNOS both in mRNA and protein levels, accompanied with the 
decrease in transcription of IFN-γ. As mentioned above, taking into consideration the close 
proximity and interaction between IEL and IEC, there could be a situation where NO induction 
by IEC and IFN-γ by IEL affect each other via a reciprocal mechanism (Fig. 13). Therefore, 
iNOS inhibition by AG suppresses NO-mediated IFN-γ transcription, followed by the decrease 
in iNOS transcription as well. 
  Another important issue to be discussed is how fasting induces intestinal iNOS expression. 
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Although little has been confirmed so far regarding the cause-and-effect relationship between 
fasting and iNOS, Qu and colleagues recently showed nNOS involvement in the regulation of 
iNOS expression in the rat small intestine. They demonstrated that nNOS, the predominant form 
(>90%) expressed in the rat small intestine, physiologically suppresses the gene expression of 
constitutive iNOS in IEC through nuclear factor kappa B (NF-κB) down-regulation, and also 
that nNOS suppression leads to IκBα degradation, followed by NF-κB activation and a 
subsequent increase in iNOS expression (39). Grongnet further showed that the intestinal nNOS 
expression is drastically reduced by fasting in the piglet jejunum (18). Consistent with these 
reports, we observed a reduced nNOS transcription after fasting (Fig. 11) with an increase in 
iNOS transcription (Fig. 8), suggesting a possible nNOS-involved mechanism underlying 
fasting-induced iNOS expression in our model (Fig. 13). However, although several other 
physiological factors, including leptin (51) and the feeding center such as the ventromedial 
hypothalamus (42), absence of luminal nutrients (16, 25) and mechanical stimuli (27), and 
reduced intestinal blood flow (16, 34) have also been reported to be involved in the regulation of 
apoptosis in the rat small intestine, further studies are needed to clarify the causative mechanism 
of iNOS expression in a fasting rat model. 
  In conclusion, these results suggest that fasting induces intestinal apoptosis through an 
iNOS-mediated mechanism, and that a close interaction could exist between iNOS and IFN-γ in 
the intestinal mucosa, affecting each other, and leading to intestinal apoptosis in fasting rats. 
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LEGENDS 
Figure 1. Experimental Design.  
  Seventy male Wistar rats were divided into two groups. Thirty-five rats in each group 
received SA or AG (20 mg/kg) subcutaneously 18 h before fasting, and were randomly 
subdivided into 5 subgroups, including a normally-fed control group, according to fasting 
durations in each group: 1) SA + ad libitum (normally-fed control), 2) SA + 24-h fast, 3) SA + 
48-h fast, 4) SA + 60-h fast, 5) SA + 72-h fast, 6) AG + ad libitum (normally-fed control), 7) AG 
+ 24-h fast, 8) AG + 48-h fast, 9) AG + 60-h fast, 10) AG + 72-h fast. All rats received SA or AG 
subcutaneously, 6, 30 and 54 h after fasting. The large block arrows represent treatment with SA 
(open block arrow) and AG (closed block arrow). At the appointed time after fasting, intestinal 
tissues were collected. Seven rats were tested in each group. 
 
Figure 2. Body weight changes expressed as the ratio of after/before fasting in SA-treated rats 
and AG-treated rats.  
  Fasting caused gradual decreases in body weight both in SA- and AG- treated groups. There 
was no difference in weight loss between the SA and AG treatment at each fasting period. Values 
are means ± SE. aP < 0.05 compared with the ad libitum-fed rats in SA-treated group. Seven rats 
were tested in each group. Open bars: SA-treated rats; closed bars: AG-treated rats.  
 
34 
 
Figure 3. Effect of fasting and AG treatment on jejunal mucosal height.  
  Although fasting caused gradual decreases in jejunal mucosal height both in SA- and 
AG-treated rats, there were significant differences (P < 0.05) in jejunal mucosal height between 
the SA- and AG-treated rats at 48 h, 60 h, and 72 h fasting periods. Values are means ± SE. aP < 
0.05 compared with the ad libitum-fed rats in SA-treated group. bP < 0.05 compared with the 
respective SA-treated group by the fasting period. Seven rats were tested in each group. Open 
bars: SA-treated rats; closed bars: AG-treated rats.  
 
Figure 4. Effect of fasting and AG treatment on cell proliferation index in the jejunum.  
  The jejunal crypt cell proliferation was histologically assessed by 5-BrdU incorporation to 
identify cells in the S phase of the cell cycle. The number of labeled cells in at least 10 
well-oriented longitudinal crypts in each sample was determined and expressed as cell 
proliferation index (5-BrdU-positive cells/10 crypts). The decrease in cell proliferation along 
with fasting was observed both with and without AG. Values are means ± SE. aP < 0.05 
compared with the ad libitum-fed rats in SA-treated group. Seven rats were tested in each group. 
Open bars: SA-treated rats; closed bars: AG-treated rats.  
 
Figure 5. Effect of fasting and AG treatment on TUNEL staining and TUNEL-positive rate in the 
jejunal villus.  
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  Apoptotic assessment of the jejunal villus was performed using TUNEL staining and 
TUNEL-positive rate. A: TUNEL staining of representative jejunal section. TUNEL-positive 
cells were observed in the tip of the jejunal villus of SA-treated rats with increasing 
TUNEL-positive cells over the indicated fasting periods (A-1, A-2, C-1, C-2, E-1, E-2, G-1, 
G-2), which were all inhibited by AG (B-1, B-2, D-1, D-2, F-1, F-2, H-1, H-2). A-1, A-2: ad 
libitum-fed with SA treatment. B-1, B-2: ad libitum-fed with AG treatment. C-1, C-2: 24-h 
fasted with SA treatment. D-1, D-2: 24-h fasted with AG treatment. E-1, E-2: 48-h fasted with 
SA treatment. F-1, F-2: 48-h fasted with AG treatment. G-1, G-2: 72-h fasted with SA treatment. 
H-1, H-2: 72-h fasted with AG treatment. Magnification: left side ×20, right side ×80. B: The 
TUNEL-positive rate was determined by dividing the number of TUNEL-positive cells by the 
total number of cells in the villi and multiplying by 200. Fasting significantly induced jejunal 
cell apoptosis, which was completely inhibited by AG over the indicated fasting periods. Values 
are means ± SE. aP < 0.05 compared with the ad libitum-fed rats in SA-treated group. bP < 0.05 
compared with the respective SA-treated group by the fasting period. Seven rats were tested in 
each group. Open bars: SA-treated rats; closed bars: AG-treated rats.  
 
Figure 6. Effect of fasting and AG treatment on apoptotic index in the jejunal villus.  
  The representative apoptotic changes by conventional light microscopy of HE-stained 
specimens (48-h fasted rat with SA treatment) are shown in Fig. 6A. The boxed areas (a, b, c) in 
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a low-power view of jejunal villi on the left (×20) are seen at higher power on the right (×80). 
Apoptotic cells in the villus are indicated by an arrow showing an intensely eosinophilic 
cytoplasm and nuclear fragmentation (a), condensed chromatin (b and c). Fig. 6B shows the AI 
in the villus of ad libitum and the indicated fasting periods (24 h, 48 h, 60 h, and 72 h) for SA 
treatment (top row) and AG treatment (bottom row). AI is defined as the total number of 
apoptotic cells at each cell position expressed as a percentage of the total number of cells 
counted at that cell position. Cell position 1 is defined as the cell at the crypt-villus junction. 
Seven rats were tested in each group. 
 
Figure 7. Effect of fasting and AG treatment on nitrite concentration in the jejunum.  
  Jejunal nitrite concentrations were measured using HPLC. AG significantly inhibited the 
fasting-induced increase in the jejunal nitrite levels. Values are means ± SE. aP < 0.05 compared 
with the ad libitum-fed rats in SA-treated group. bP < 0.05 compared with the respective 
SA-treated group by the fasting period. Seven rats were tested in each group. Open bars: 
SA-treated rats; closed bars: AG-treated rats.  
 
Figure 8. Effect of fasting and AG treatment on jejunal expression of iNOS mRNA.  
  Levels of iNOS mRNA (101 bp) were assessed by densitometric analysis and are expressed as 
ratios of iNOS mRNA to GAPDH densitometry units. Fasting significantly induced iNOS 
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mRNA, which was suppressed by AG. Values are means ± SE. aP < 0.05 compared with the ad 
libitum-fed rats in SA-treated group. Seven rats were tested in each group. Open bars: 
SA-treated rats; closed bars: AG-treated rats.  
 
Figure 9. Effect of fasting and AG treatment on jejunal expression of IFN-γ mRNA.  
  Levels of IFN-γ mRNA (140 bp) were assessed by densitometric analysis and are expressed as 
ratios of IFN-γ mRNA to GAPDH densitometry units. Fasting significantly induced IFN-γ 
mRNA, which was suppressed by AG. Values are means ± SE. aP < 0.05 compared with the ad 
libitum-fed rats in SA-treated group. Seven rats were tested in each group. Open bars: 
SA-treated rats; closed bars: AG-treated rats.  
 
Figure 10. Light micrographs of the jejunum immunohistochemically stained for iNOS.    
  Negligible iNOS staining was noted in the crypts and only faint staining in the cytoplasm at 
the villus-tip epithelial cells of ad libitum-fed rats (A-1 and A-2). Decrease of these stainings 
with AG treatment in ad libitum-fed rats (B-1 and B-2). Fasting for 24 h, 48 h, and 72 h revealed 
heavily positive iNOS immunostaining along the mucosal epithelial monolayer of the jejunum 
(C-1, C-2; E-1, E-2; and G-1, G-2). These enhanced iNOS immunoreactivities were almost 
completely inhibited by AG treatment (D-1, D-2; F-1, F-2; and H-1, H-2). A-1, A-2: ad 
libitum-fed with SA treatment. B-1, B-2: ad libitum-fed with AG treatment. C-1, C-2: 24-h 
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fasted with SA treatment. D-1, D-2: 24-h fasted with AG treatment. E-1, E-2: 48-h fasted with 
SA treatment. F-1, F-2: 48-h fasted with AG treatment. G-1, G-2: 72-h fasted with SA treatment. 
H-1, H-2: 72-h fasted with AG treatment. Magnification: left side ×20, right side ×80.  
 
Figure 11. Effect of fasting on jejunal expression of nNOS mRNA.  
  Levels of nNOS mRNA (146 bp) were assessed by densitometric analysis and are expressed 
as ratios of nNOS mRNA to GAPDH densitometry units. In contrast to iNOS (Fig. 7), fasting 
significantly attenuated nNOS mRNA levels. Values are means ± SE. aP < 0.05 compared with 
the ad libitum-fed rats in SA-treated group. Seven rats were tested in each group. 
 
Figure 12. Effect of fasting and AG treatment on DNA oxidative damage in the jejunum.  
  DNA oxidative damage was assessed by levels of 8-OHdG in the jejunum. In SA-treated 
groups, fasting increased jejunal 8-OHdG levels at 24 h, 48 h, and 72 h fasting periods compared 
with the ad libitum-fed rats. AG significantly inhibited the fasting-induced increases in the 
jejunal 8-OHdG levels at 48 h and 72 h fasting periods compared with the respective SA-treated 
group at each fasting period. aP < 0.05 compared with the ad libitum-fed rats in SA-treated 
group. bP < 0.05 compared with the respective SA-treated group at each fasting period. Seven 
rats were tested in each group. Open bars: SA-treated rats; closed bars: AG-treated rats. 
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Figure 13. Schematic summary diagram of fasting-induced intestinal apoptosis.  
  This schematic summary diagram depicts a possible role of nNOS in the regulation of iNOS 
activity upstream in the process of fasting-induced apoptosis. iNOS-derived NO may play a 
central role downstream in this process, inducing IFN-γ, and leading to IEC apoptosis. Note a 
close interaction between iNOS-released NO in IEC and IEL-derived IFN-γ through a 
ROS-mediated mechanism in the intestinal mucosa. IEC: intestinal epithelial cell, IEL: 
intraepithelial lymphocyte. 
 
Table 1. Enterocyte apoptosis of the jejunal villus by conventional light microscopy of 
HE-stained specimens. 
  Significant decreases in cell numbers per villus column of fasting rats were noted compared to 
that of the ad libitum-fed rats over the indicated time periods. Conventional light microscopy 
detecting representative apoptotic changes showed significant increases both in ratio of 
apoptotic cells to one villus column and in AI (6.8- to 8.6-fold increase: P < 0.05) in fasted rats 
with SA, and also showed significant inhibitory effects of AG on fasting-induced apoptosis over 
the indicated fasting periods. Values are means ± SE; n = 7 per group. aP < 0.05 compared with 
the ad libitum-fed rats in SA-treated group. bP < 0.05 compared with the respective SA-treated 
group at each fasting period. AI in the villus is defined as the total number of apoptotic cells 
expressed as a percentage of the total number of cells counted in 50 well-oriented villus columns. 
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Fig. 13
ad libitum 24 h fast 48 h fast 60 h fast 72 h fast
Cells per villus 
column, n
84 ± 1 72 ± 1 a 70 ± 2 a 70 ± 2 a 68 ± 1 a
SA
Apoptotic cells per 
villus column, n
0.04 ± 0.01 0.24 ± 0.04 a 0.29 ± 0.02 a 0.29 ± 0.02 a 0.29 ± 0.04 a
Apoptotic index, % 0.05 ± 0.01 0.34 ± 0.07 a 0.42 ± 0.03 a 0.42 ± 0.02 a 0.43 ± 0.05 a
Cells per villus 
column, n
85 ± 1 75 ± 1 76 ± 3 75 ± 1 75 ± 2
AG
Apoptotic cells per 
villus column, n
0.04 ± 0.01 0.17 ± 0.02 b 0.15 ± 0.01 b 0.19 ± 0.03 b 0.17 ± 0.03 b
Apoptotic index, % 0.05 ± 0.01 0.22 ± 0.02 b 0.20 ± 0.02 b 0.25 ± 0.04 b 0.23 ± 0.04 b
Table. 1
